![Page 1: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/1.jpg)
Claus Møldrup, PhD (pharm.) Associate Professor, University of CopenhagenDirector TBWA\WorldHealthFormer visiting Professor, INSEAD
Forestillinger omfremtidensfarmasøytiskePraksis
- From content to care
![Page 2: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/2.jpg)
![Page 3: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/3.jpg)
![Page 4: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/4.jpg)
![Page 5: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/5.jpg)
![Page 6: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/6.jpg)
![Page 7: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/7.jpg)
![Page 8: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/8.jpg)
![Page 9: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/9.jpg)
N=47537
The European Social Survey (the ESS) is a biennial multi-country survey covering 25 nations. These data is from 2004/2005
Accept of using pharmaceuticals in different areas in average across EU
17,70%
26,30%
34,50%37,30%
49,20%
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
Approve or stronglyapprove if healthy
people use medicines toloose w eight
Approve or stronglyapprove if healthy
people use medicines tofeel happier
Approve or stronglyapprove if healthy
people use medicines toimprove sex life
Approve or stronglyapprove if healthy
people use medicines toreduce hair loss
Approve or stronglyapprove if healthy
people use medicines toimprove memory
![Page 10: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/10.jpg)
![Page 11: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/11.jpg)
![Page 12: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/12.jpg)
![Page 13: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/13.jpg)
![Page 14: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/14.jpg)
![Page 15: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/15.jpg)
![Page 16: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/16.jpg)
![Page 17: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/17.jpg)
![Page 18: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/18.jpg)
![Page 19: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/19.jpg)
![Page 20: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/20.jpg)
![Page 21: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/21.jpg)
![Page 22: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/22.jpg)
![Page 23: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/23.jpg)
SalesR&DMarketing
![Page 24: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/24.jpg)
![Page 25: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/25.jpg)
SalesR&DMarketing
![Page 26: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/26.jpg)
![Page 27: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/27.jpg)
VS
Product Product + service = a new product
New product = apply for patent/trademarkNew product ≠ generic, analog, copy = less comp.
![Page 28: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/28.jpg)
VS
![Page 29: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/29.jpg)
![Page 30: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/30.jpg)
Communication/Marketing/support/legal/economical
Chains
R&D + clinical testuniversities/research
organizations
Communication/Marketing/support/legal/economical
Associations
Sales / QAChains
Sales / QAIndividuals
![Page 31: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/31.jpg)
![Page 32: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/32.jpg)
![Page 33: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/33.jpg)
Bulk
LAB
OfficePharmacist
Manufactory
Customer
Produktion
Service
Pharmacy layout in 1950
![Page 34: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/34.jpg)
disposal
disposal
OfficePharmacist
disposal
Customer
Produktion
Service
Pharmacy layout in 2009!!!!
![Page 35: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/35.jpg)
Kitchen
Customer
CustomerCustomer
Customer
Customer
Produktion
Service
Restaurant layout in 2009
Customer Costomer
Customer
Customer
![Page 36: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/36.jpg)
![Page 37: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/37.jpg)
Introduktionstilbud
59 kr. pr. mdr*
Større sikkerhed for dig og din familie
Et abonnement på Panodil tilbyder større sikkerhed og support til dig og din familie.
Abonnementet indeholderSMS smertedagbog med online ekspert evaluering hver måned.Mulighed for gratis at skifte til anden formulering f. eks hvis barnet ikke kan lide smagen. 2 pakninger per måned.SmerteudredningsspørgeskemaInformation til teenagere om risiko ved overdosering
* Minimuns abonnement periode 6 måneder minimums pris 354 kr.
![Page 38: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/38.jpg)
$
![Page 39: Forestillinger om fremtidens farmasøytiske Praksis - Apotek fileForestillinger om fremtidens farmasøytiske Praksis - From content to care. N=47537 The European Social Survey (the](https://reader030.vdocuments.site/reader030/viewer/2022040716/5e1fd7149263bb006802b36c/html5/thumbnails/39.jpg)